PharmGKB summary: abacavir pathway
Pharmacogenet Genomics
.
2014 May;24(5):276-82.
doi: 10.1097/FPC.0000000000000040.
Authors
Julia M Barbarino
1
,
Deanna L Kroetz
,
Russ B Altman
,
Teri E Klein
Affiliation
1
Departments of aGenetics bBioengineering, Stanford University, Stanford cDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, USA.
PMID:
24625462
PMCID:
PMC4074515
DOI:
10.1097/FPC.0000000000000040
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Dideoxynucleosides / metabolism
Dideoxynucleosides / therapeutic use*
Humans
Pharmacogenetics*
Substances
Dideoxynucleosides
abacavir
Grants and funding
R24 GM061374/GM/NIGMS NIH HHS/United States
U01 GM061390/GM/NIGMS NIH HHS/United States
R24 GM61374/GM/NIGMS NIH HHS/United States